US 7919523
Inhibitors of aspartyl protease
granted A61PA61P31/18
Quick answer
US patent 7919523 (Inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/18